CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL

CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL

Aim. To compare effects of long term therapy with сarvedilol and bisoprolol on heart and renal functions, heart rate variability (HRV) and quality of life in elderly patients with chronic heart failure (CHF).Material and methods. We examined 40 patients aged 60-75 years on the 15-30 day after myocar...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	chronic heart failure сarvedilol bisoprolol quality of life left ventricular function microalbuminuria heart rate variability
Online Access:	https://www.rpcardio.online/jour/article/view/363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION
by: M. E. Statsenko, et al.
Published: (2016-01-01)

The comparative analysis of the influence of bisoprolol and carvedilol on the course of heart failure of ischemic origin in patients with concomitant atrial fibrillation and diabetes mellitus
by: N.M. Kulaiets, et al.
Published: (2024-11-01)

Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care
by: Ivana Kacirova, et al.
Published: (2025-06-01)

Renal function and chronic heart failure treatment effectiveness in the elderly
by: M. E. Statsenko, et al.
Published: (2007-04-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Bisoprolol in cardiovascular disease treatment
by: S. N. Tolpygina, et al.
Published: (2008-12-01)

Trimetazidine effects on heart and kidney functional status, and quality of life in long-term complex treatment of chronic heart failure in elderly patients
by: M. E. Statsenko, et al.
Published: (2005-10-01)

OPTIMAL USE OF BETA-BLOCKERS IN CASE OF CHRONIC HEART FAILURE
by: N. A. Shostak, et al.
Published: (2016-09-01)

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

CARDIO-SELECTIVE Β-BLOCKER BISOPROLOL IN THE MANAGEMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2011-06-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
by: Yu. V. Lapina, et al.
Published: (2008-08-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

DYNAMICS OF STRUCTURAL AND FUNCTIONAL STATUS OF MYOCARDIUM DUE TO COMBINATION THERAPY WITH AMLODIPINE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: I. L. Zapesochnaya, et al.
Published: (2015-09-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction
by: R. T. Shukurov, et al.
Published: (2011-04-01)

COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME
by: V. M. Provotorov, et al.
Published: (2016-01-01)

Effects of bisoprolol combined with torasemide on cardiac electrophysiology in patients with acute myocardial infarction and heart failure
by: Li Jing, et al.
Published: (2025-08-01)

REGULATORY-ADAPTIVE STATE IN EVALUATION OF BISOPROLOL AND NEBIVOLOL THERAPY EFFECTIVENESS FOR VENTRICULAR ARRHYTHMIA
by: I. Z. Shubitidze, et al.
Published: (2016-12-01)

REGULATORY-ADAPTIVE STATUS IN COMPARISON OF BISOPROLOL AND SOTALOL EFFICACY IN VENTRICULAR RHYTHM DISORDERS
by: V. G. Tregubov, et al.
Published: (2018-03-01)

Microalbuminuria as an indicator for LVH severity in patients with primary hypertension
by: Govind Tripathi, et al.
Published: (2025-03-01)

CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. R. Giljarevskiy, et al.
Published: (2016-01-01)

KIDNEY AND HEART INVOLVEMENT IN ARTERIAL HYPERTENSION: EVOLUTION OF VIEW FROM R. BRIGHT AND E.M. TAREEV TO PRESENT DAYS
by: V. I. Podzolkov, et al.
Published: (2010-06-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.
by: V. A. Vasylenko
Published: (2015-09-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome
by: Vasylenko V.A.
Published: (2015-09-01)

EVALUATION OF CARVEDILOL EFFECTS ON THE BASIC DATA OF LEFT VENTRICLE SYSTOLIC AND DIASTOLIC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
by: L. N. Mingazetdinova, et al.
Published: (2001-08-01)

NOVEL COMBINATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR PERINDOPRIL AND HIGHLY SELECTIVE β-ADRENOBLOCKER BISOPROLOL: PRIME AMONG THE EQUAL
by: O. D. Ostroumova, et al.
Published: (2018-06-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Development and Validation of a Novel Analytical Method (Ion Pair HPLC) For Separating and Determining Bisoprolol Fumarate and Carvedilol in Pure and Their Pharmaceutical Forms.
by: Duaa Alhuseen, et al.
Published: (2024-06-01)

EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE
by: I. I. Esenova, et al.
Published: (2015-09-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: V. A. Nevzorova, et al.
Published: (2015-12-01)

FUNCTIONAL MYOCARDIAL CONDITION IN CHRONIC HEART FAILURE WITH CONCOMITANT OBESITY
by: V. Z. Netyazhenko, et al.
Published: (2014-04-01)

Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)

PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)

Adherence to treatment as an integral component of the management of patients with heart failure
by: V. N. Larina, et al.
Published: (2024-02-01)

Treatment of chronic heart failure with a very low dose of antibodies to C-fragment of type 1 angiotensin II receptor
by: T. M. Poponina, et al.
Published: (2009-08-01)

Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan
by: Y. M. Budach, et al.
Published: (2013-04-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)